Position in NTLA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$26,683,504
+$5,756,118 QoQ
Shares Held
2,081,397
-10.6% QoQ
Ownership
1.49%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. NTLA ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,683,504 | 2,081,397 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $20,927,386 | 2,327,852 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $104,009,882 | 6,022,576 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $38,616,152 | 4,116,861 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $27,030,047 | 3,801,695 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $44,477,599 | 3,814,546 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $52,937,493 | 2,576,034 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $52,317,921 | 2,337,709 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $72,759,847 | 2,644,851 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $77,597,715 | 2,545,022 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $97,735,548 | 3,090,941 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $116,190,657 | 2,849,207 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $98,969,846 | 2,655,483 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $87,858,249 | 2,518,150 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $85,649,629 | 1,530,551 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $63,985,396 | 1,236,194 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $94,107,573 | 1,294,999 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $180,109,431 | 1,523,253 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $153,741,129 | 1,146,039 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $112,968,328 | 697,723 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $40,555,255 | 505,330 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $63,999,150 | 1,176,455 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $23,594,238 | 1,186,833 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $16,395,409 | 779,991 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,935,458 | 648,852 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||